Works by Jessurun, Naomi T.

Results: 32

Quantification of longitudinal patient-reported burden of adverse drug reactions attributed to the use of TNF-α inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study.

Published in:

Expert Opinion on Drug Safety, 2025, v. 24, n. 7, p. 815, doi. 10.1080/14740338.2024.2383697

By:

König, Benthe H.;
Gosselt, Helen R.;
van Lint, Jette A.;
Kosse, Leanne J.;
van den Bemt, Bart J. F.;
ten Klooster, Peter M.;
Vonkeman, Harald E.;
Jessurun, Naomi T.

Publication type:

Article

Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system.

Published in:

Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 520, doi. 10.1002/pds.5175

By:

Thomas, Pepijn W. A.;
West, Rachel L.;
Russel, Maurice G. V. M.;
Jansen, Jeroen M.;
Kosse, Leanne J.;
Jessurun, Naomi T.;
Römkens, Tessa E. H.;
Hoentjen, Frank

Publication type:

Article

Prosthetic infections following tocilizumab treatment in patients with rheumatoid arthritis.

Published in:

Rheumatology, 2024, v. 63, n. 10, p. e290, doi. 10.1093/rheumatology/keae228

By:

Louters, Annemieke;
Oosterhout, Maikel Van;
Burgemeister, Lot;
Jessurun, Naomi T;
Lint, Jette A Van

Publication type:

Article

Patients with inflammatory rheumatic diseases: quality of self-reported medical information in a prospective cohort event monitoring system.

Published in:

Rheumatology, 2020, v. 59, n. 6, p. 1253, doi. 10.1093/rheumatology/kez412

By:

Kosse, Leanne J;
Jessurun, Naomi T;
Hebing, Renske C F;
Huiskes, Victor J B;
Spijkers, Karin M;
Bemt, Bart J F van den;
Nurmohamed, Mike T

Publication type:

Article

Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity.

Published in:

2021

By:

Jessurun, Naomi T.;
Drent, Marjolein;
Wijnen, Petal A.;
Harmsze, Ankie M.;
van Puijenbroek, Eugène P.;
Bekers, Otto;
Bast, Aalt

Publication type:

journal article

Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.

Published in:

Drug Safety, 2021, v. 44, n. 5, p. 581, doi. 10.1007/s40264-021-01045-3

By:

Giraud, Eline L.;
Thomas, Pepijn W. A.;
van Lint, Jette A.;
van Puijenbroek, Eugene P.;
Römkens, Tessa E. H.;
West, Rachel L.;
Russel, Maurice G. V. M.;
Jansen, Jeroen M.;
Jessurun, Naomi T.;
Hoentjen, Frank

Publication type:

Article

Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases.

Published in:

2020

By:

van Lint, Jette A.;
Jessurun, Naomi T.;
Hebing, Renske C. F.;
Hoentjen, Frank;
Tas, Sander W.;
Vonkeman, Harald E.;
van Doorn, Martijn B. A.;
Sobels, Annemieke;
Spuls, Phyllis I.;
van Puijenbroek, Eugene P.;
Nurmohamed, Michael T.;
van den Bemt, Bart J. F.

Publication type:

journal article

Comorbidities of sarcoidosis.

Published in:

Annals of Medicine, 2022, v. 54, n. 1, p. 1014, doi. 10.1080/07853890.2022.2063375

By:

Tana, Claudio;
Drent, Marjolein;
Nunes, Hilario;
Kouranos, Vasilis;
Cinetto, Francesco;
Jessurun, Naomi T.;
Spagnolo, Paolo

Publication type:

Article

Hospital registration of adverse drug reactions in electronic health records: importance and contribution to pharmacovigilance.

Published in:

Expert Opinion on Drug Safety, 2024, v. 23, n. 7, p. 925, doi. 10.1080/14740338.2023.2282582

By:

Alloush, Roba;
van Lint, Jette;
van Marum, Rob J.;
Hermens, Walter W.A.J.J.;
Jessurun, Naomi T.

Publication type:

Article

Impact of adverse drug reactions on the treatment pathways of early rheumatoid arthritis patients: a prospective observational cohort study.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 8, p. 753, doi. 10.1080/14740338.2023.2194628

By:

Velthuis, Kimberly;
Poppelaars, Fenna;
ten Klooster, Peter M.;
Vonkeman, Harald E.;
Jessurun, Naomi T.

Publication type:

Article

Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 6, p. 501, doi. 10.1080/14740338.2023.2181340

By:

Gosselt, Helen R.;
van Lint, Jette A.;
Kosse, Leanne J.;
Spuls, Phyllis I.;
Vonkeman, Harald E.;
Tas, Sander W.;
Hoentjen, Frank;
Nurmohamed, Michael T.;
van den Bemt, Bart J.F.;
van Doorn, Martijn B.A.;
Jessurun, Naomi T.

Publication type:

Article

First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 6, p. 485, doi. 10.1080/14740338.2023.2172157

By:

Velthuis, Kimberly;
Jessurun, Naomi T.;
Nguyen, Thi D.M.;
Scholl, Joep;
Jansen, Jurriaan R.G.;
van Lint, Jette A.;
Kosse, Leanne J.;
ten Klooster, Peter M.;
Vonkeman, Harald E.

Publication type:

Article

Patients' and health-care professionals' perspectives on adverse drug reaction burden attributed to the use of biological DMARDs: a qualitative study.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 5, p. 417, doi. 10.1080/14740338.2023.2134344

By:

Westerink, Henrike J.;
Kosse, Leanne J.;
Jessurun, Naomi T.;
Tubergen, Astrid van;
Vonkeman, Harald E.;
Nurmohamed, Mike T.;
van den Bemt, Bart J.F.;
de Vries, Marieke

Publication type:

Article

Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 3, p. 203, doi. 10.1080/14740338.2022.2115479

By:

Roest, Lieke H.;
Kosse, Leanne J.;
van Lint, Jette A.;
Gosselt, Helen R.;
Scholl, Joep H.G.;
van Puijenbroek, Eugène;
Vonkeman, Harald E.;
Tas, Sander W.;
Nurmohamed, Michael T.;
van den Bemt, Bart J.F.;
Jessurun, Naomi T.

Publication type:

Article

Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs).

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 3, p. 195, doi. 10.1080/14740338.2022.2110237

By:

de Boer, Merel;
Gosselt, Helen R;
Jansen, Jurriaan;
van Doorn, Martijn B.A;
Hoentjen, Frank;
Nurmohamed, Michael T;
Spuls, Phyllis I;
Tas, Sander W;
Vonkeman, Harald E;
Jessurun, Naomi T

Publication type:

Article

Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals.

Published in:

Expert Opinion on Drug Safety, 2022, v. 21, n. 5, p. 699, doi. 10.1080/14740338.2022.2020756

By:

Geeven, Isa P. A. C.;
Jessurun, Naomi T.;
Wasylewicz, Arthur T. M.;
Drent, Marjolein;
Spuls, Phyllis I.;
Hoentjen, Frank;
van Puijenbroek, Eugène P.;
Vonkeman, Harald E.;
Grootens, Koen P.;
van Doorn, Martijn B. A.;
van Den Bemt, Bart J. F.;
Bekker, Charlotte L.

Publication type:

Article

Neuropsychiatric adverse drug reactions associated with low dose methotrexate in rheumatoid arthritis patients.

Published in:

Expert Opinion on Drug Safety, 2022, v. 21, n. 3, p. 417, doi. 10.1080/14740338.2022.2003328

By:

Van Lint, Jette A.;
Bakker, Tom;
ten Klooster, Peter M.;
van Puijenbroek, Eugene P.;
Vonkeman, Harald E.;
Jessurun, Naomi T.

Publication type:

Article

Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes.

Published in:

Expert Opinion on Drug Safety, 2021, v. 20, n. 12, p. 1565, doi. 10.1080/14740338.2021.1963436

By:

Kosse, Leanne J;
Weits, Gerda;
Vonkeman, Harald E;
Tas, Sander W;
Hoentjen, Frank;
Van Doorn, Martijn BA;
Spuls, Phyllis I;
D'Haens, Geert R;
Nurmohamed, Michael T;
van Puijenbroek, Eugène P;
Van Den Bemt, Bart JF;
Jessurun, Naomi T

Publication type:

Article

Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients.

Published in:

Expert Opinion on Drug Safety, 2020, v. 19, n. 12, p. 1617, doi. 10.1080/14740338.2020.1830058

By:

Giraud, Eline L.;
Jessurun, Naomi T.;
van Hunsel, Florence P.A.M.;
van Puijenbroek, Eugene P.;
van Tubergen, Astrid;
Ten Klooster, Peter M.;
Vonkeman, Harald E.

Publication type:

Article

Stakeholders' perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases.

Published in:

Expert Opinion on Drug Safety, 2020, v. 19, n. 11, p. 1521, doi. 10.1080/14740338.2020.1803826

By:

Kosse, Leanne J.;
Jessurun, Naomi T.;
Vonkeman, Harald E.;
Tas, Sander W.;
Nurmohamed, Mike T.;
Hoentjen, Frank;
van Doorn, Martijn B.A.;
van Puijenbroek, Eugène P.;
van den Bemt, Bart J.F.;
de Vries, Marieke

Publication type:

Article

Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics.

Published in:

Expert Opinion on Drug Safety, 2020, v. 19, n. 8, p. 1049, doi. 10.1080/14740338.2020.1781090

By:

Kosse, Leanne J.;
Weits, Gerda;
Vonkeman, Harald E.;
Spuls, Phyllis I.;
Van Den Bemt, Bart J.F.;
Tas, Sander W.;
Hoentjen, Frank;
Nurmohamed, Mike T.;
Van Doorn, Martijn B.A.;
Van Puijenbroek, Eugène P.;
Jessurun, Naomi T.

Publication type:

Article

Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 8, p. 2770, doi. 10.3390/ijms21082770

By:

Jessurun, Naomi T.;
Wijnen, Petal A.;
Bast, Aalt;
van Puijenbroek, Eugène P.;
Bekers, Otto;
Drent, Marjolein

Publication type:

Article

Body weight gain in clozapine‐treated patients: Is norclozapine the culprit?

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 853, doi. 10.1111/bcp.14992

By:

Jessurun, Naomi T.;
Derijks, Hieronymus J.;
van Marum, Rob J.;
Jongkind, Amy;
Giraud, Eline L.;
van Puijenbroek, Eugène P.;
Grootens, Koen P.

Publication type:

Article

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10‐hydroxynortriptyline serum levels‐A prospective pharmacokinetic study.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1529, doi. 10.1111/bcp.14455

By:

Jessurun, Naomi T.;
Vermeulen Windsant, Annemieke;
Mikes, Oenone;
Puijenbroek, Eugène P.;
Marum, Rob J.;
Grootens, Koen;
Derijks, Hieronymus J.

Publication type:

Article

Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 1041, doi. 10.1111/bcp.13887

By:

Lokhorst, Bianca;
Rolfes, Leàn;
Jessurun, Naomi T.

Publication type:

Article

Muscle spasms: an unexpected adverse drug reaction of pemetrexed?

Published in:

Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 138, doi. 10.1177/1758834016677941

By:

de Rouw, Hendrika J. A.;
Jessurun, Naomi T.;
Masen-Poos, Lucie J. P.;
Derijks, Hieronymus J.

Publication type:

Article

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.

Published in:

Drug Safety, 2024, v. 47, n. 4, p. 355, doi. 10.1007/s40264-024-01400-0

By:

Drent, Marjolein;
Wijnen, Petal A.;
Jessurun, Naomi T.;
Harmsze, Ankie M.;
Bekers, Otto;
Bast, Aalt

Publication type:

Article

Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient's Perspective.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 1039, doi. 10.1007/s40264-023-01343-y

By:

van Lint, Jette A.;
Sonnenberg, Marlieke;
Vonkeman, Harald E.;
van den Bemt, Bart J. F.;
van Puijenbroek, Eugene P.;
Jessurun, Naomi T.

Publication type:

Article

Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 541, doi. 10.1007/s40259-023-00592-8

By:

van Lint, Jette A.;
Jessurun, Naomi T.;
Tas, Sander W.;
Vonkeman, Harald E.;
van Doorn, Martijn B. A.;
Hoentjen, Frank;
Nurmohamed, Michael T.;
van Puijenbroek, Eugene P.;
van den Bemt, Bart J. F.

Publication type:

Article

Development of a text mining algorithm for identifying adverse drug reactions in electronic health records.

Published in:

JAMIA Open, 2024, v. 7, n. 3, p. 1, doi. 10.1093/jamiaopen/ooae070

By:

Burgt, Britt W M van de;
Wasylewicz, Arthur T M;
Dullemond, Bjorn;
Jessurun, Naomi T;
Grouls, Rene J E;
Bouwman, R Arthur;
Korsten, Erik H M;
Egberts, Toine C G

Publication type:

Article

Fatigue patterns surrounding biologic disease-modifying antirheumatic drug injection in patients with an inflammatory rheumatic disease: an ecological momentary assessment study.

Published in:

Rheumatology International, 2025, v. 45, n. 1, p. 1, doi. 10.1007/s00296-024-05779-y

By:

van Lint, Jette A.;
Vriezekolk, Johanna E.;
Jessurun, Naomi T.;
den Broeder, Alfons A.;
van den Bemt, Bart J. F.;
Huiskes, Victor J. B.

Publication type:

Article

Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals.

Published in:

2021

By:

van Lint, Jette A.;
Jessurun, Naomi T.;
Tas, Sander W.;
van den Bemt, Bart J. F.;
Nurmohamed, Michael T.;
van Doorn, Martijn B. A.;
Spuls, Phyllis I.;
van Tubergen, Astrid M.;
ten Klooster, Peter M.;
van Puijenbroek, Eugene P.;
Hoentjen, Frank;
Vonkeman, Harald E.

Publication type:

journal article